Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5: 591-602.
Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501: 346-54.
Turtoi A, De Pauw E, Castronovo V. Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies. Am J Pathol 2011; 178: 12-8.
Turtoi A, Dumont B, Greffe Y, et al. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. J Proteome Res 2011; 10: 3160-82.
Dumont B, Castronovo V, Peulen O, et al. Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. J Proteome Res 2012; 11: 2247-60.
Merline R, Schaefer RM, Schaefer L. The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal 2009; 3: 323-35.
Kou I, Nakajima M, Ikegawa S. Expression and regulation of the osteoarthritis-associated protein asporin. J Biol Chem 2007; 282: 32193-9.
Maris P, Blomme A, Palacios AP, et al. Asporin is a fibroblast-derived TGF-?1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer. PLoS Med 2015; 12: e1001871.
Moyret-Lalle C, Pommier R, Bouard C, et al. Plasticité des cellules cancéreuses et dissémination métastatique. Med Sci (Paris) 2016; 32: 725-31.
Giavazzi R, Garofalo A, Bani MR, et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990; 50: 4771-5.
Reed JR, Leon RP, Hall MK, Schwertfeger KL. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. Breast Cancer Res 2009; 11: R21.
Hong DS, Hui D, Bruera E, et al. MABp1, a first-inclass true human antibody targeting interleukin-1? in refractory cancers: an open-label, phase 1 doseescalation and expansion study. Lancet Oncol 2014; 15: 656-66.
Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 2014; 25: 719-34.